# Sentinext Therapeutics Sdn Bhd

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/sentinext-therapeutics-sdn-bhd

- Industry: Biotechnology
- Headquarters: Malaysia
- Website: www.sentinext.com
- Total disclosed funding: $28M
- Latest round: Series B (Jan 25, 2018)
- Investors on record: 6

## About

Sentinext Therapeutics Sdn Bhd is a Malaysia-based company specializing in premium domain names, particularly in the technology and innovation sectors, enhancing businesses' online presence.Sentinext Therapeutics Sdn Bhd was founded in 2009 and operates from Malaysia. The company focuses on selling premium domain names, including Sentinext.com, which caters to a global audience in various industries such as technology, finance, healthcare, and education. The firm raised USD 1.09 million in Series B funding on January 25, 2018, led by Malaysia Venture Capital Management and Innocorp Ventures. The firm has completed a total of 4 deals since its inception, with a current valuation of USD 23.63 mn.Sentinext.com specializes in offering premium domain names, with a focus on the technology and innovation sectors. Its core product, the domain name Sentinext.com, aims to significantly enhance a company's online identity and visibility, enabling effective audience engagement across multiple industries. The firm serves a worldwide client base, providing businesses with strategic online branding opportunities to improve their search engine presence and brand loyalty.In 2022, Sentinext Therapeutics reported zero revenue with an EBITDA of USD -3,276.70. The company's revenue model is based on one-time transaction fees for domain acquisitions and annual renewals, allowing clients to secure their domain names and maintain their online presence efficiently.Sentinext Therapeutics plans to leverage its recent Series B funding of USD 1.09 million to expand its product offerings and enhance its market reach. Future strategies include the development of new premium domain names tailored to emerging industries and expanding into new geographic markets, although specific timelines and regions for this expansion have not been disclosed. The company aims to utilize its funding to support these initiatives and strengthen its position in the digital domain market.

## Funding rounds

- Series B, Jan 25, 2018, $1.1M — Jelawang Capital, Innocorp Ventures
- Series B, Nov 20, 2014, $15M — Malaysia Venture Capital Management, Malaysian Technology Development, Xeraya Capital, Innocorp Ventures
- Series B, Dec 25, 2011, $6.3M — Burrill & Company, Malaysian Technology Development, Xeraya Capital
- Series A, Dec 1, 2011, $6.2M — Malaysian Technology Development, Xeraya Capital

## Investors

- Malaysian Technology Development (https://capitalatlas.ai/funds/malaysian-technology-development) — Series A, Series B
- Xeraya Capital (https://capitalatlas.ai/funds/xeraya-capital) — Series A, Series B
- Burrill & Company (https://capitalatlas.ai/funds/burrill-company) — Series B
- Malaysia Venture Capital Management — Series B
- Innocorp Ventures — Series B
- Jelawang Capital (https://capitalatlas.ai/funds/jelawang-capital) — Series B